Den absolutte biotilgængelighed (70%) for insulin glulisin var ens for injektionsstederne, og der var en lav intra- patient variabilitet (11%).
The absolute bioavailability (70%) of insulin glulisine was similar between injection sites and of low intra- subject variability (11%CV).